MAR 18, 2015 6:00 AM PDT

Keynote -Dopamine System Dysregulation in the Pathophysiology of Schizophrenia and Depression

Presented at: Neuroscience
Speaker
  • Distinguished Professor of Neuroscience, Professor of Psychiatry and Psychology Department of Neuroscience, University of Pittsburgh
    BIOGRAPHY

Abstract

The dopamine-containing neurons of the midbrain have been implicated in a broad array of psychiatric disorders, ranging from schizophrenia to drug abuse and depression. However, studies seem to indicate that it is not the dopamine neurons themselves that are responsible for these pathological states, but instead the disorders appear to arise due to a disruption of dopamine neuron regulation by afferent inputs. Dopamine neurons recorded in vivo are known to exhibit multiple functional activity states, including baseline tonic firing and phasic activation in response to salient stimuli. Phasic burst firing is believed to be the behaviorally relevant “signal” of the dopamine neuron, whereas the level of tonic discharge represents the “gain” or the level of amplification of this signal. This tonic gain is differentially regulated by multiple brain regions, including the hippocampus, the amygdala, and the prefrontal cortex. Disruptions in these regions can interfere with the normal tonic/phasic balance within the dopamine system. Electrophysiological and behavioral studies in animal models of psychiatric disorders, as well as and human imaging studies in patients, suggest that this disruption may underlie the pathological state of the dopamine system that is present in psychiatric disorders. Specifically, we found that hippocampal hyperactivity in schizophrenia may be responsible for the hyperdopaminergic state of psychosis, whereas prefrontal cortical-amygdala overdrive diminishes reward-related dopamine neuron activity leading to anhedonia in depression. This type of information can contribute both to a better understanding of the pathophysiology of major psychiatric disorders, as well as glean insights into novel avenues of treatment and potentially in preventing the emergence of these disorders.


Show Resources
You May Also Like
JUN 28, 2022 7:00 AM PDT
JUN 28, 2022 7:00 AM PDT
Date: June 28, 2022 Time: 3:00pm (BST), 4:00pm (CET), 9:00am (CST), 7am (PST) Light-sheet microscopy is an extremely versatile imaging technique with a vast range of implementations that are...
AUG 24, 2022 7:00 AM PDT
AUG 24, 2022 7:00 AM PDT
Date: August 24, 2022 Time: 7:00am (PDT), 10:00pm (EDT), 4:00pm (CEST) Light field microscopy was first introduced in 2006, and allows users to capture the 4D light field within the microsco...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
JUN 21, 2022 6:00 AM PDT
JUN 21, 2022 6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
APR 26, 2022 7:00 AM PDT
C.E. CREDITS
APR 26, 2022 7:00 AM PDT
Date: April 19, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) High-content (HC) phenotypic profiling approaches are a powerful tool to study the effect of biological, genetic, and ch...
MAR 18, 2015 6:00 AM PDT

Keynote -Dopamine System Dysregulation in the Pathophysiology of Schizophrenia and Depression

Presented at: Neuroscience


Show Resources
Loading Comments...
Show Resources
Attendees